Find information on the dosing and administration of ADSTILADRIN®, including instillation details. See Important Safety Info.

2 DOSAGE AND ADMINISTRATION Important Administration Instructions ADSTILADRIN is for intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral administration.

Oct 10, 2025 · Detailed dosage guidelines and administration information for Adstiladrin (nadofaragene firadenovec-vncg). Includes dose adjustments, warnings and precautions.

Dosing and Administration The recommended dose of Adstiladrin is 75 mL at a concentration of 3 x 1011 viral particles (vp)/mL instilled once every 3 months into the bladder via a urinary catheter. …

Medscape - Bladder cancer dosing for Adstiladrin (nadofaragene firadenovec), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost …

May 4, 2023 · Dosing Limits Quantity Limit (max daily dose) [NDC Unit]: − Adstiladrin suspension 3 × 1011 viral particles (vp)/mL (20 mL single-dose vial): 4 vials every three months for four doses only …

Dosage interruptions of ADSTILADRIN due to an adverse reaction occurred in 54 (34%) patients. Adverse reactions in >10% of patients that required dosage interruption included instillation site …

DOSAGE AND ADMINISTRATION: Administer ADSTILADRIN by intravesical instillation only. ADSTILADRIN is not for intravenous use, topical use, or oral administration. USE IN SPECIFIC …

Dec 9, 2024 · Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer. Includes …

Nadofaragene firadenovec-vncg (ADSTILADRIN) National Drug Monograph September 2023 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist …